Page 456 - Feline Cardiology
P. 456

Index  481


              Euthyroid sick syndrome, 401      Field of view, for cMRI in cats, 143  Fundus
              Event monitoring, electrocardiography   Filaroides spp., lung parasitic lesions and,   of geriatric cat with systemic
                      and, 80–81                       359                              hypertension, 326
              E’ wave, in cats with HCM vs. without   Fine-needle aspiration, cardiac neoplasia   tapetal, normal, for comparative
                      HCM, 140                         and, 203                         purposes, 326
              Excessive left ventricular moderator   FIP. See Feline infectious peritonitis  Furosemide, 123, 165, 373, 447, 452, 460
                      bands, 207–208            First-degree atrioventricular (AV) block, 237  arrhythmogenic right ventricular
              Exercise intolerance               causes of, 240                         cardiomyopathy and, 191
                congenital heart malformations and, 85  defined, 237               congestive heart failure
                low output heart failure and, 261  5-chamber view, normal aortic spectral   medical therapy and monitoring of
                syncope and, 17                        Doppler tracing from, 61         cats with, 285t
              External event monitors,          Fixed subaortic stenosis, SAM vs., 122  congestive heart failure and
                      electrocardiography and, 80–81,   Fluid administration        adjunctive physiologic effects of, 287
                      81                         anesthesia in patient with cardiac   drug properties of, 286
              Extracellular matrix remodeling,         disease and, 418             function/dosing of, 286
                      biomarkers and, 69         congestive heart failure and, 269  outpatient treatment for, 284
              Exudates, pleural effusion and, 19, 20   heart disease concurrent with kidney   pharmacodynamic effects of,
                      (box 3.1)                        disease and, 368                 287
              Eyes, systemic hypertensive        heart failure and, 163             refractory, 164, 293, 294
                      decompensation and, 331   Fluid filtration, Starling equation and   SAM of the mitral valve with, 434
                                                       factors of, 260              standard treatment of, 286
              F                                 Fluid therapy in cats with heart disease,   dilated cardiomyopathy and, 186
              Fainting. See Syncope                    368–373                     for dyspneic cats with pulmonary
              “False tendons” (excessive moderator   acute decompensation of cardiac or   edema, 162
                      bands), 207                      renal disease and, 370      electrolyte abnormalities and, 296
              Fascicular blocks, 237, 241–242    arterial thromboembolism and, 311  HCM and
              FDA. See Food and Drug Administration  cardiorenal syndrome and, 296, 368–373  hospitalized cats with, 290, 291
              Fecal examination, lungworm infestation   critical care with, in cats with cardiac   severe, symptomatic cats with, 160,
                      and, 26                          disease, 378–379                 161
              Feline heart disease, recognizing, ix  heart disease with extracardiac   symptomatic cats with heart failure
              Feline infectious pericarditis, pericardial   disorders and, 367          and, 167
                      effusion and, 346          hyperkalemia addressed with, 312  heart failure and, 163, 180
              Feline lower urinary tract signs, cardiac   FLUTD, FLUTS. See Feline lower urinary   indications, dosage, available sizes, 450
                      disease and, 373–374             tract signs                 recurrent heart failure and, 297
              Feline panleukopenia virus, association   Fluticasone, for asthma, 375  references for, 464, 465, 466, 468
                      with hypertrophic         Focal basilar concentric hypertrophy, of   renal insufficiency, heart failure and
                      cardiomyopathy, 108              interventricular septum, HCM     lower doses of, 166
              FeLV/FIV, dyspnea/coughing and, 26       and, 129
              FeLV test, cardiac neoplasia and, 202  Focal basilar septal hypertrophy, 129  G
              Femoral arterial pulse quality, poor, low   Fonaparinux, 318       Gadolinium accumulation, detection of
                      output heart failure and, 271  Food and Drug Administration, 441  diffuse interstitial fibrosis by DE
              Femoral pulse, HCM and, 120       Forelimb paresis, acute, arterial       and, 145
              Fenoldopam, 445                          thromboembolism and, 309  Gallop heart sounds, 6, 10–11
                indications, dosage, available sizes, 449  Fortekor (benazepril), 449  assessing, acute decompensation of
                references for, 466              indications, dosage, available sizes, 444  cardiac or renal disease and,
              Fentanyl, 416                     4-chamber view                          370
                analgesia for arterial thromboembolism   echocardiographic image, 59, 61, 61  excessive moderator bands and, 208
                      and, 310                   obtained from left apical review, 62  fluid therapy and onset of, 379
                anesthesia, for cardiac patient, 414t  Fourth heart sound (S 4 ), gallop sounds   HCM and, 119
              Fibrin, arterial thrombi and, 307        and, 10, 11                  incidental discovery of, 118
              Fibrinolysis, normal TEG tracing from   FOV. See Field of view       hyperthyroidism and, 400
                      feline patient and, 319   Foxglove, HCM and, contraindications, 165  systemic hypertension and, 333
              Fibrin degradation/split products, arterial   Fractious cats, anesthetizing, 418  Genetic diseases, 425
                      thromboembolism and, 311  Fragmin (low molecular weight heparin),   Genetic penetrance, 425–426
              Fibrocartilaginous infarction, arterial   449                      Genetic screening, 427–428
                      thromboembolism and, 308–309  indications, dosage, available sizes, 450  HCM and, 148
              Fibronectin concentration, of pleural   Free thyroxine level, HCM diagnosis and,   heterozygous cats, 428
                      effusion, measuring, 282         123                         homozygous cats, 428
              Fibrosis, myocardial stiffness and, 115   Fundic abnormalities, systemic   mutation screening, 427–428
                      (See also Replacement fibrosis)  hypertension and, 332       recommendations, 428
   451   452   453   454   455   456   457   458   459   460   461